| Date Filed | Type | Description |
| 05/26/2023 |
4
| Kapadia Sandip (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 03/31/2023 |
4
| Kapadia Sandip (CFO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Paid exercise price by delivering 15,414 shares
@ $33.36, valued at
$514.2k
Exercised 30,000 restricted stock units
@ $0 |
|
| 12/02/2022 |
4
| Kapadia Sandip (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Sold 5,000 shares
@ $1.1929, valued at
$6k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2021 |
4
| Kapadia Sandip (CFO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 60,000 restricted stock units
@ $0
Granted 230,000 options
@ $29.03, valued at
$6.7M
|
|
| 03/31/2021 |
3
| Kapadia Sandip (CFO) has filed a Form 3 on Harmony Biosciences Holdings, Inc. |
| 01/26/2021 |
4
| Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 17,200 shares
@ $0
Granted 26,900 options to buy
@ $29.46, valued at
$792.5k
|
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,763 shares
@ $32.78, valued at
$57.8k
|
|
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2020 |
4
| Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 615 shares
@ $58.4, valued at
$35.9k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/27/2020 |
4
| Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 5,600 shares
@ $0
Granted 9,200 options to buy
@ $99.66, valued at
$916.9k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 615 shares
@ $79.17, valued at
$48.7k
|
|
| 04/03/2019 |
4
| Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 615 shares
@ $111.5, valued at
$68.6k
|
|
| 01/18/2019 |
4
| Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 4,500 shares
@ $0
Granted 7,200 options to buy
@ $110.8, valued at
$797.8k
|
|
| 01/03/2019 |
4
| Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,118 shares
@ $100.79, valued at
$112.7k
|
|
| 10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2018 |
4
| Kapadia Sandip (CFO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Granted 6,900 shares
@ $0
Granted 10,500 options to buy
@ $58.74, valued at
$616.8k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/06/2016 |
4
| Kapadia Sandip (CFO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Granted 15,000 shares
@ $0
Granted 18,000 options to buy
@ $146.36, valued at
$2.6M
|
|
| 07/06/2016 |
3
| Kapadia Sandip (CFO) has filed a Form 3 on INTERCEPT PHARMACEUTICALS INC |